Skip to main content
. 2018 Mar 25;176(5):1115–1127. doi: 10.1002/ajmg.a.38658

Table 3.

Biochemical results of extensive investigations of four patients with ECHS1 deficiency

Patient 1 Patient 2 Patient 3 Patient 4
Plasma lactate (mmol/L) 1.47–>5.46
(0.6–2.4)
2.46
(0.6–2.4)
1.50–>5.68
(0.6–2.4)
1.92–>4.92
(0.6–2.4)
Plasma alanine
(µmol/L)
337–>764
(176–480)
599
(0–675)
423–>471
(0–675)
383–>559
(176–480)
Plasma proline
(µmol/L)
256–>717
(89–287)
468
(0–435)
211
(0–435)
277–>300
(89–287)
Acylcarnitine analysis
(DBS)
Normal profile
Slight increase in C4OH/isoC4OH
Not performed Slightly decreased free carnitine and long chain AC. C4OH/isoC4OH not increased Normal profile
C4OH/isoC4OH not increased
Organic acid analysis Mild increases in
3‐MGC
3‐HIVA
2,3‐dihydroxy‐2‐methylbutyrate
Slight increases in
3‐MGC
2,3‐dihydroxy‐2‐methylbutyrate
Marked lactate
Slight increase in MMA
Mild increase in
3‐MGC
2,3‐dihydroxy‐2‐
methylbutyrate
Mild dicarboxylic aciduria
Slight increases in MMA
3‐MGC
2,3‐dihydroxy‐2‐methylbutyrate
PDH activity in fibroblasts Reduced activity
No mutations found
Not performed Normal activity Not performed
Muscle respiratory
Chain complexes (C)
Normal CI, II, II, IV activities Not performed Decreased Complex III activity Not performed
Other AUH and multiple single gene tests known to cause LS all negative SURF1 genetics was negative Multiple single gene tests and WES negative Single gene tests and WES all negative

Results in bold indicate abnormal findings. AC = acylcarnitines; C4OH/isoC4OH = hydroxybutyryl/hydroxyisobutyryl‐carnitine; DBS = dried blood spot; LS = Leigh syndrome; 3‐MGC = 3‐methylglutaconate; 3‐HIVA = 3‐hydroxyisovalerate; MMA = methylmalonic acid; PDH = pyruvate dehydrogenage activity.